Last reviewed: June 1, 2026

2017JCI Insight

LRRK2 is expressed in microglia and differentially regulates microglial pro- and anti-inflammatory responses

Cook DA, Kanber M, et al.

Abstract summary

Demonstrated that LRRK2 is expressed in microglia and regulates cytokine production and microglial inflammatory responses. LRRK2 G2019S mutant microglia show exaggerated pro-inflammatory responses. LRRK2 kinase inhibition attenuates microglial activation. Established microglia as a key cellular context for LRRK2 function in PD.

Evidence labels

animal modelhuman tissuein vitro assay

Targets

Diseases

  • Parkinson's disease

Species

mouse, human

Methods

flow cytometry, ELISA, small molecule pharmacology

Therapeutic relevance

Microglia are a key cellular target of LRRK2 kinase inhibitors beyond dopaminergic neurons.

Last reviewed: June 1, 2026